-
1
-
-
84867750417
-
Evolution of Hemoglobinopathy Prevention in Africa: Results Problems and Prospect
-
Fattoum S. Evolution of Hemoglobinopathy Prevention in Africa: Results, Problems and Prospect. Mediterr J Hematol Infect Dis. 2009;1:e2009005
-
(2009)
Mediterr J Hematol Infect Dis
, vol.1
-
-
Fattoum, S.1
-
2
-
-
84877969967
-
Hematopoietic stem cell transplantation in talassemia and related disorders
-
Angelucci E, Pilo F, Targhetta C, Pettinau M, Depau C, Cogoni C, Usai S, Pani M, Dess L, Baronciani D. Hematopoietic stem cell transplantation in talassemia and related disorders. Mediterr J Hematol Infect Dis. 2009;1:e2009015
-
(2009)
Mediterr J Hematol Infect Dis
, vol.1
-
-
Angelucci, E.1
Pilo, F.2
Targhetta, C.3
Pettinau, M.4
Depau, C.5
Cogoni, C.6
Usai, S.7
Pani, M.8
Dess, L.9
Baronciani, D.10
-
3
-
-
0034669984
-
Alloimmunization and erythrocyte autoimmunization in transfusion dependant thalassemia patients of predominantly Asian descent
-
Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP. Alloimmunization and erythrocyte autoimmunization in transfusion dependant thalassemia patients of predominantly Asian descent. Blood 2000;96:3369-3373
-
(2000)
Blood
, vol.96
, pp. 3369-3373
-
-
Singer, S.T.1
Wu, V.2
Mignacca, R.3
Kuypers, F.A.4
Morel, P.5
Vichinsky, E.P.6
-
4
-
-
0029942003
-
The risk of transfusion-transmitted viral infections The retrovirus Epidemiology Donor study
-
Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The retrovirus Epidemiology Donor study. NEngl J Med, http://dx.doi.org/10.1056/NEJM199606273342601, 1996;334: 1685-1690.
-
(1996)
NEngl J Med
, vol.334
, pp. 1685-1690
-
-
Schreiber, G.B.1
Busch, M.P.2
Kleinman, S.H.3
Korelitz, J.J.4
-
5
-
-
34247568569
-
Coexistence of autoantibodies and alloantibodies to red cells due to blood transfusion
-
Ahrens N, Pruss A, Kohne A, Kiesewetter H, Salama A. Coexistence of autoantibodies and alloantibodies to red cells due to blood transfusion. Transfusion. http://dx.doi.org/10.1111/j.1537-2995.2007.01194.x 2007; 47:813-816
-
(2007)
Transfusion
, vol.47
, pp. 813-816
-
-
Ahrens, N.1
Pruss, A.2
Kohne, A.3
Kiesewetter, H.4
Salama, A.5
-
6
-
-
60549094300
-
A study on endocrine dysfunction in thalassaemia
-
Ghosh S., Bandyopadhyay SK, Bandyopadhyay R, Ro, Maisnam I, Ghosh M.K. A study on endocrine dysfunction in thalassaemia.J Indian Med Assoc2008; 106: 655-659
-
(2008)
J Indian Med Assoc
, vol.106
, pp. 655-659
-
-
Ghosh, S.1
Bandyopadhyay, S.K.2
Bandyopadhyay, R.3
Ro4
Maisnam, I.5
Ghosh, M.K.6
-
7
-
-
33748807736
-
Survival of medically treated thalassemia patients in Cyprus Trends and risk factorsover the period 1908-2004
-
Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou EK, et al. Survival of medically treated thalassemia patients in Cyprus. Trends and risk factorsover the period 1908-2004. Haematologica 2006;91: 1187-1192
-
(2006)
Haematologica
, vol.91
, pp. 1187-1192
-
-
Telfer, P.1
Coen, P.G.2
Christou, S.3
Hadjigavriel, M.4
Kolnakou, A.5
Pangalou, E.K.6
-
8
-
-
0025296108
-
Antibody to hepatitis C virus in multiply transfused patients with thalassaemiamajor
-
Wonke B, Hoffbrand AV, Brown D, Dusheiko G. Antibody to hepatitis C virus in multiply transfused patients with thalassaemiamajor.J ClinPatho1990;43: 638-640.
-
(1990)
J ClinPatho
, vol.43
, pp. 638-640
-
-
Wonke, B.1
Hoffbrand, A.V.2
Brown, D.3
Dusheiko, G.4
-
9
-
-
0028141421
-
Antibodies to hepatitis C virus in thalassaemia
-
Angelucci E. Antibodies to hepatitis C virus in thalassaemia.Haematologica1994;79: 353-355.
-
(1994)
Haematologica
, vol.79
, pp. 353-355
-
-
Angelucci, E.1
-
10
-
-
0842324888
-
Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolyticanemia?
-
Young PP, Uzieblo A, Trulock E, Lublin DM, Goodnough LT. Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolyticanemia?.Transfusion, http://dx.doi.org/10.1046/j.0041-1132.2003.00589.x, 2004; 44: 67-72.
-
(2004)
Transfusion
, vol.44
, pp. 67-72
-
-
Young, P.P.1
Uzieblo, A.2
Trulock, E.3
Lublin, D.M.4
Goodnough, L.T.5
-
11
-
-
0242440019
-
RBC alloimmunization and autoimmunization among transfusion-dependant Arab thalassemia patients
-
Ameen R, Al-Shemmari S, Al-Humood S, ChowdhurryRI,Al-Eyaadi O, Al-Bashir A.RBC alloimmunization and autoimmunization among transfusion-dependant Arab thalassemia patients. Transfusion. http://dx.doi.org/10.1046/j.1537-2995.2003.00549.x 2003;43: 1604-1610
-
(2003)
Transfusion
, vol.43
, pp. 1604-1610
-
-
Ameen, R.1
Al-Shemmari, S.2
Al-Humood, S.3
Chowdhurry, R.I.4
Al-Eyaadi, O.5
Al-Bashir, A.6
-
12
-
-
56449083645
-
Transfusion medicine in developing country-Alloantibodies to red blood cells in multitransfused patients in Saudi Arabia
-
Gader AMA, Al Ghomlas AK, Al Momen AK. Transfusion medicine in developing country-Alloantibodies to red blood cells in multitransfused patients in Saudi Arabia.Transf. apheresis science2008;39:199-204.
-
(2008)
Transf. apheresis science
, vol.39
, pp. 199-204
-
-
Gader, A.M.A.1
Al Ghomlas, A.K.2
Al Momen, A.K.3
-
14
-
-
80053454295
-
High frequency ofautoimmunizationamong transfusion-dependent Tunisian thalassemia patients
-
Dhouib N,Mezri M,Hmida H,Mellouli F, Kaabi H, Ouderni M, et al. High frequency ofautoimmunizationamong transfusion-dependent Tunisian thalassemia patients. Transf apheresis 2011;45: 199-20
-
(2011)
Transf apheresis
, vol.45
, pp. 199-220
-
-
Dhouib, N.1
Mezri, M.2
Hmida, H.3
Mellouli, F.4
Kaabi, H.5
Ouderni, M.6
-
15
-
-
0031876331
-
Survivalanddiseasecomplications in thalassemia major
-
Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, Gamberini MR, et al. Survivalanddiseasecomplications in thalassemia major. Ann N Y AcadSci. http://dx.doi.org/10.1111/j.1749-6632.1998.tb10479.x, 1998;850: 227-231
-
(1998)
Ann N Y AcadSci
, vol.850
, pp. 227-231
-
-
Borgna-Pignatti, C.1
Rugolotto, S.2
De Stefano, P.3
Piga, A.4
Di Gregorio, F.5
Gamberini, M.R.6
-
16
-
-
84877970840
-
Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up
-
CappelliniMD,Bejaoui M, Agaoglu L, Canatan D, CapraM,Cohen A, et al.Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up. Blood 2011;22:115-120
-
(2011)
Blood
, vol.22
, pp. 115-120
-
-
Cappellini, M.D.1
Bejaoui, M.2
Agaoglu, L.3
Canatan, D.4
Capra, M.5
Cohen, A.6
-
17
-
-
77950425913
-
Deferasirox pharmacokinetics in patients with adequate versus inadequate response
-
ChimomasD,Smith AL, BrausteinJ,Finkelstein Y, Pereira L, Bergmann AK, et al.Deferasirox pharmacokinetics in patients with adequate versus inadequate response. Blood. http://dx.doi.org/10.1182/blood-2009-05-222729 2009;114:4009-4013
-
(2009)
Blood
, vol.114
, pp. 4009-4013
-
-
Chimomas, D.1
Smith, A.L.2
Braustein, J.3
Finkelstein, Y.4
Pereira, L.5
Bergmann, A.K.6
-
18
-
-
0030022344
-
Clinical experience of management of thalassemia: theSardinian experience
-
Cao A., Galanello R., Rosatelli MC., Argiolu F., DeVirgiliis S. Clinical experience of management of thalassemia: theSardinian experience. Semin Hematol 1996; 33:66-75
-
(1996)
Semin Hematol
, vol.33
, pp. 66-75
-
-
Cao, A.1
Galanello, R.2
Rosatelli, M.C.3
Argiolu, F.4
DeVirgiliis, S.5
-
19
-
-
79957564332
-
Etiology of congestive heart failure in children
-
Rashid J, Khalil M, Natiq M, Anwar S, Nazir MM. Etiology of congestive heart failure in children. Pak Ped J 2003; 27: 145-51.
-
(2003)
Pak Ped J
, vol.27
, pp. 145-151
-
-
Rashid, J.1
Khalil, M.2
Natiq, M.3
Anwar, S.4
Nazir, M.M.5
-
20
-
-
0036181740
-
J Endocrine complications in patients with beta-thalassemia major
-
Aydinok Y, Darcan S, Polat A, Kavakli K, Nigli G, Coker M et al. J Endocrine complications in patients with beta-thalassemia major.Trop Pediatr2002;48:50-54.
-
(2002)
Trop Pediatr
, vol.48
, pp. 50-54
-
-
Aydinok, Y.1
Darcan, S.2
Polat, A.3
Kavakli, K.4
Nigli, G.5
Coker, M.6
-
21
-
-
33750049951
-
Multi-Centre Study of Iron Overload Research Group Increased prevalence of iron-overload associated endocrinopathy in thalassaemiaversus sickle-cell disease
-
Fung EB, Harmatz PR, Lee PD, Milet M, Bellevue R, Jeng MR, et al.: Multi-Centre Study of Iron Overload Research Group.Increased prevalence of iron-overload associated endocrinopathy in thalassaemiaversus sickle-cell disease. Br J Haematol 2006; 135:574-582.
-
(2006)
Br J Haematol
, vol.135
, pp. 574-582
-
-
Fung, E.B.1
Harmatz, P.R.2
Lee, P.D.3
Milet, M.4
Bellevue, R.5
Jeng, M.R.6
-
22
-
-
0030848911
-
Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia
-
Jensen CE, Tuck SM, Old J, et al. Incidence of endocrine complications and clinical disease severity related to genotype analysis and iron overload in patients with beta-thalassaemia. Eur J Haematol. http://dx.doi.org/10.1111/j.1600-0609.1997.tb00729.x 1997;59: 76-81
-
(1997)
Eur J Haematol
, vol.59
, pp. 76-81
-
-
Jensen, C.E.1
Tuck, S.M.2
Old, J.3
-
23
-
-
0029063078
-
Italian Working Group on Endocrine Complications in Nonendocrine Diseases Multicentre study on prevalence of endocrine complications in thalassaemia, major
-
Italian Working Group on Endocrine Complications in Nonendocrine Diseases Multicentre study on prevalence of endocrine complications in thalassaemia major. Clin Endocrinol 1995;42:581-586.
-
(1995)
Clin Endocrinol
, vol.42
, pp. 581-586
-
-
-
24
-
-
0028059813
-
Efficacy of desferoxamine in preventingcomplications of ironoverload in patients with thalassemia major
-
Brittenham GM, Griffith PM, NienhuisAW, McLaren CE, Young NS, Tucker EE, et al. Efficacy of desferoxamine in preventingcomplications of ironoverload in patients with thalassemia major. N Engl J Med 1994;331:567-573
-
(1994)
N Engl J Med
, vol.331
, pp. 567-573
-
-
Brittenham, G.M.1
Griffith, P.M.2
Nienhuis, A.W.3
McLaren, C.E.4
Young, N.S.5
Tucker, E.E.6
-
25
-
-
12544260252
-
Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF)
-
De Sanctis V, Eleftheriou A, Malaventura C. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF). Pediatr Endocrinol Rev 2004;2:249-255
-
(2004)
Pediatr Endocrinol Rev
, vol.2
, pp. 249-255
-
-
De Sanctis, V.1
Eleftheriou, A.2
Malaventura, C.3
-
26
-
-
0025108768
-
Treatment of Cooley's anemia
-
Fosburg MT, Nathan D.G. Treatment of Cooley's anemia. Blood 1990;76: 435-444
-
(1990)
Blood
, vol.76
, pp. 435-444
-
-
Fosburg, M.T.1
Nathan, D.G.2
-
27
-
-
0035725754
-
Risk of Infection and Death Among Post-splenectomy Patients
-
Bisharat N, Omari H, Lavi I. Risk of Infection and Death Among Post-splenectomy Patients. Journal of Infection. http://dx.doi.org/10.1053/jinf.2001.0904 2001;43:182-186
-
(2001)
Journal of Infection
, vol.43
, pp. 182-186
-
-
Bisharat, N.1
Omari, H.2
Lavi, I.3
-
28
-
-
0037376609
-
Functions of the splenic remnant after subtotal splenectomy for treatment of severe splenic injuries
-
Resende V, Petroianu A. Functions of the splenic remnant after subtotal splenectomy for treatment of severe splenic injuries. Am Surg2003. http://dx.doi.org/10.1016/S0002-9610(02)01407-1;185:311-315
-
(2003)
Am Surg
, vol.185
, pp. 311-315
-
-
Resende, V.1
Petroianu, A.2
-
29
-
-
85047693774
-
Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children
-
Rice HE, Oldham KT, Hillery CA, Skinner MA, O'Hara SM,Ware RE. Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children. Ann Surg. http://dx.doi.org/10.1097/01.SLA.0000048453.61168.8F, 2003;237:281-288
-
(2003)
Ann Surg
, vol.237
, pp. 281-288
-
-
Rice, H.E.1
Oldham, K.T.2
Hillery, C.A.3
Skinner, M.A.4
O'Hara, S.M.5
Ware, R.E.6
-
31
-
-
0025551986
-
Cardiac disease-free survival in patients with thalassemia major treated with subcutaneous deferoxamine An update of the Toronto cohort
-
Olivieri NF, McGee A, Liu P, Koren G, Freedman MH, Benson L. Cardiac disease-free survival in patients with thalassemia major treated with subcutaneous deferoxamine. An update of the Toronto cohort.Ann NY AcadSci, http://dx.doi.org/10.1111/j.1749-6632.1990.tb24374.x, 1990;612:585-586
-
(1990)
Ann NY AcadSci
, vol.612
, pp. 585-586
-
-
Olivieri, N.F.1
McGee, A.2
Liu, P.3
Koren, G.4
Freedman, M.H.5
Benson, L.6
-
32
-
-
29744463847
-
Longitudinal study of survival and causes of death in patients with thalassemia major in Greece
-
Ladis V, Chouliaras G, Bedousi H, et al. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ann N Y AcadSc i, http://dx.doi.org/10.1196/annals.1345.067, 2005;1054:445-450
-
(2005)
Ann N Y AcadSc i
, vol.1054
, pp. 445-450
-
-
Ladis, V.1
Chouliaras, G.2
Bedousi, H.3
-
33
-
-
0024404844
-
The prevention of thalassemia in Sardinia
-
Cao A, Rosatelli C, Galanello R, Monni G, Olla G, Cossu P. et al. The prevention of thalassemia in Sardinia. Clin Genet. 1989; 36:277-85.
-
(1989)
Clin Genet
, vol.36
, pp. 277-285
-
-
Cao, A.1
Rosatelli, C.2
Galanello, R.3
Monni, G.4
Olla, G.5
Cossu, P.6
-
34
-
-
56049119080
-
Prevalence and preventive measures for thalassemia in Hazara region of NWFP Pakistan
-
Buki MK, Qayum I, Siddiqui N. Prevalence and preventive measures for thalassemia in Hazara region of NWFP Pakistan. JAMC 1998; 10: 28-31.
-
(1998)
JAMC
, vol.10
, pp. 28-31
-
-
Buki, M.K.1
Qayum, I.2
Siddiqui, N.3
|